CD44 and cancer: Taken together, these results demonstrate that the equilibrium of CD44+/CD24−/low cells is more tightly regulated in non-tumorigenic than cancer cells in response to an acute 10 Gy dose of radiation; deregulation of this process may play a role in carcinogenesis by providing an advantage to cells that are more capable of being reprogramed to a stem-like state.